The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity

Figure 5

The relationship between the CDC20 molecule and the survival rate of KIRC patients verified by nomogram: (a) nomogram to predict the overall survival rate of KIRC patients in the TCGA database at 1, 3, and 5 years; (b–d) ROC curve used to identify the validity of nomogram; (e–g) calibration chart for nomogram conformance test in TCGA database.

(a)

(b)

(c)

(d)

(e)

(f)

(g)